Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial
William W. Busse, Eugene R. Bleecker, J Mark FitzGerald, Gary T. Ferguson et autres
315 citationsThe Lancet Respiratory Medicine